Search in:

Advanced search

Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 15

Submit an article Journal homepage

757

Views

CrossRef citations to date

Altmetric

Reviews

Treatment of migraine with prophylactic drugs

Stefan Evers University of Münster, Department of Neurology, Albert-Schweitzer-Street 33, 48129 Münster, Germany +49 251 834 8196; +49 251 834 8181; [email protected]

, MD PhD

Pages 2565-2573 | Published online: 19 Sep 2008

Cite this article
https://doi.org/10.1517/14656566.9.15.2565

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine – report of an EFNS task force. Eur J Neurol 2006;13:560-72
PubMed Web of Science ®Google Scholar
Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-62
PubMed Web of Science ®Google Scholar
Diener HC, Pfaffenrath V, Limmroth V, et al. Therapie der Migräneattacke und Migräneprophylaxe. In: Kommission Leitlinien der Deutschen Gesellschaft für Neurologie, editors. Gemeinsame Leitlinie der Deutschen Gesellschaft für Neurologie und der Deutschen Migräne – und Kopfschmerzgesellschaft. Volume 3. Stuttgart: Thieme; 2005. p. 494-508
Google Scholar
Rabkin R, Stables DP, Levin NW, Suzman MM. Propranolol and prophylaxis of angina pectoris. Am J Cardiol 1966;18:370-80
PubMed Web of Science ®Google Scholar
Wissmann A, Feuersenger A, Gendolla A, et al. Entwicklung eines Migräneprophylaxe-screeninginstruments (MPS). Schmerz 2007;21:430-8
PubMed Web of Science ®Google Scholar
Diener HC, Föh M, Iaccarino C, et al. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. Cephalalgia 1996;16:441-7
PubMed Web of Science ®Google Scholar
Diener HC, Hartung E, Chrubasik J, et al. For the study group: a comparative study of acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomised, controlled, double-blind, parallel group phase III study. Cephalalgia 2001;21:140-4
PubMed Web of Science ®Google Scholar
Diener H, Matias-Guiu J, Hartung E, et al. Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily. Cephalalgia 2002;22:209-21
PubMed Web of Science ®Google Scholar
Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991;31:333-40
PubMed Web of Science ®Google Scholar
Diener HC, Limmroth V. The treatment of migraine. Rev Contemp Pharmacother 1994;5:271-84
Google Scholar
Silberstein SD, Goadsby PJ. Migraine. Preventive treatment. Cephalalgia 2002;22:491-512
PubMed Web of Science ®Google Scholar
Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2004;(2):CD003225
Google Scholar
Wörz R, Reinhardt-Benmalek B, Föh MG, et al. Migräneprophylaxe durch Bisoprolol. Ergebnisse einer Doppelblindstudie versus Metoprolol. Fortschr Med 1992;110:268-72
PubMedGoogle Scholar
Van De Ven LL, Franke CL, Koehler PJ. Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study. Cephalalgia 1997;17:596-9
PubMed Web of Science ®Google Scholar
Stellar S, Ahrens SP, Meibohm AR, Reines SA. Migraine prevention with timolol. A double-blind crossover study. JAMA 1984;252:2576-80
PubMed Web of Science ®Google Scholar
Tfelt-Hansen P, Standnes B, Kangasneimi P, et al. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 1984;69:1-8
PubMed Web of Science ®Google Scholar
Stensrud P, Sjaastad O. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache 1980;20:204-7
PubMed Web of Science ®Google Scholar
Forssman B, Lindblad CJ, Zbornikova V. Atenolol for migraine prophylaxis. Headache 1983;23:188-90
PubMed Web of Science ®Google Scholar
Johannsson V, Nilsson LR, Widelius T, et al. Atenolol in migraine prophylaxis a double-blind cross-over multicentre study. Headache 1987;27:372-4
PubMed Web of Science ®Google Scholar
Nanda RN, Johnson RH, Gray J, et al. A double blind trial of acebutolol for migraine prophylaxis. Headache 1978;18:20-2
PubMed Web of Science ®Google Scholar
Ekbom K. Alprenolol for migraine prophylaxis. Headache 1975;15:129-32
PubMed Web of Science ®Google Scholar
Ekbom K, Zetterman M. Oxprenolol in the treatment of migraine. Acta Neurol Scand 1977;56:181-4
PubMed Web of Science ®Google Scholar
Diener HC. Flunarizine for migraine prophylaxis. In: Diener HC, editor, Drug treatment of migraine and other headaches. Basel: Karger; 2000. p. 269-78
Google Scholar
Evers S, Pothmann, R, überall M, et al. Therapie idiopathischer Kopfschmerzen im Kindesalter. Nervenheilkunde 2001;20:306-15
Google Scholar
Brandes J, Saper J, Diamond M, et al. Migr-002 study group: topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291:965-73
PubMed Web of Science ®Google Scholar
Diener HC, Tfelt-Hansen P, Dahlöf C, et al. On behalf of the migr-003 study group: topiramate in migraine prophylaxis: results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004;251:943-50
PubMed Web of Science ®Google Scholar
Silberstein SD, Neto W, Schmitt J, Jacobs D. Migr-001 study group: topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004;61:490-5
PubMed Web of Science ®Google Scholar
Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev 2004;(3):CD003226
Google Scholar
Lainez MJ, Freitag FG, Pfeil J, et al. Time course of adverse events most commonly associated with topiramate for migraine prevention. Eur J Neurol 2007;14:900-6
PubMed Web of Science ®Google Scholar
Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol 1995;52:281-6
PubMed Web of Science ®Google Scholar
Klapper J. On behalf of the divalproex sodium in migraine prophylaxis study group: divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 1997;17:103-8
PubMed Web of Science ®Google Scholar
Freitag F, Collins S, Carlson H, et al. Migraine study group: a randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 2002;58:1652-9
PubMed Web of Science ®Google Scholar
Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis: changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychchiatry 1973;36:684-90
PubMed Web of Science ®Google Scholar
Couch JR, Ziegler DK, Hassanein R. Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant drugs. Neurology 1976;26:121-7
PubMed Web of Science ®Google Scholar
Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol 1979;36:695-9
PubMed Web of Science ®Google Scholar
Ziegler DK, Hurwitz A, Hassanein RS. Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol 1987;44:486-9
PubMedGoogle Scholar
Adelman LC, Adelman JU, Von Seggern R, Mannix LK. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000;40:572-80
PubMed Web of Science ®Google Scholar
Bulut S, Berilgen MS, Baran A, et al. Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg 2004;107:44-8
PubMed Web of Science ®Google Scholar
Ozyalcin SN, Talu GK, Kiziltan E, et al. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005;45:144-52
PubMed Web of Science ®Google Scholar
Mathew NT, Rapoport A, Saper J, et al. Efficacy of gabapentin in migraine prophylaxis. Headache 2001;41:119-28
PubMed Web of Science ®Google Scholar
Ziegler DK, Ellis DJ. Naproxen in prophylaxis of migraine. Arch Neurol 1985;42:582-4
PubMed Web of Science ®Google Scholar
Welch KMA, Ellis DJ, Keenan PA. Successful migraine prophylaxis with naproxen sodium. Neurology 1985;35:1304-10
PubMed Web of Science ®Google Scholar
Evers S, Mylecharane EJ. Nonsteroidal anti-inflammatory and miscellaneous drugs in migraine prophylaxis. In: Olesen J, Goadsby PJ, Ramadan NM, et al., editors, The headaches. Philadelphia: Lippincott, Williams & Wilkins; 2006. p. 553-66
Google Scholar
Visser WH, Malbecq W, Strohmaier K, et al. Preventive treatment of migraine headache with rofecoxib. In: Olesen J, Silberstein SD, Tfelt-Hansen P, editors, Preventive pharmacotherapy of headache disorders. 3rd edition. Oxford: Oxford University Press; 2004. p. 44-9
Google Scholar
Diener H, Rahlfs V, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 2004;51:89-97
PubMed Web of Science ®Google Scholar
Lipton RB, Göbel H, Einhäupl KM, et al. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 2004;63:2240-4
PubMed Web of Science ®Google Scholar
Diener HC, Pfaffenrath V, Schnitker J, et al. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention – a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 2005;25:1031-41
PubMed Web of Science ®Google Scholar
Pfaffenrath V, Diener HC, Fischer M, et al. On Behalf of the Investigators. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis – a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 2002;22:523-32
PubMed Web of Science ®Google Scholar
Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine – a double-blind, placebo-controlled study. Cephalalgia 1996;16:436-40
PubMed Web of Science ®Google Scholar
Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257-63
PubMed Web of Science ®Google Scholar
Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994;14:328-30
PubMed Web of Science ®Google Scholar
Schoenen J, Jacquy J, Lenaerts M. High-dose power riboflavin as a novel prophylactic antimigraine therapy: results from a double-blind, randomized, placebo-controlled trial. Cephalalgia 1997;17:244
Google Scholar
Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis – a randomized controlled trial. Neurology 1998;50:466-70
PubMed Web of Science ®Google Scholar
Boehnke C, Reuter U, Flach U, et al. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 2004;11:475-7
PubMed Web of Science ®Google Scholar
Sandor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005;64:713-5
PubMed Web of Science ®Google Scholar
Mylecharane EJ. 5-HT2 receptor antagonists and migraine therapy. J Neurol 1991;238(Suppl 1):S45-52
Google Scholar
Brighina F, Palermo A, Aloisio A, et al. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study. Clin Neuropharmacol 2006;29:338-42
PubMed Web of Science ®Google Scholar
Schrader H, Stovner LJ, Helde G, et al. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo-controlled, crossover trial. BMJ 2001;322:19-22
PubMed Web of Science ®Google Scholar
Tronvik E, Stovner LJ, Helde G, et al. Prophylactic treatment of migraine with an angiotensin II receptor blocker. A randomized controlled trial. JAMA 2002;289:65-9
Web of Science ®Google Scholar
Evers S. Investigating prophylactic botulinum toxin type A for chronic headache disorders. Expert Opin Investig Drugs 2006;15:1161-6
PubMed Web of Science ®Google Scholar
Steiner TJ, Findley LJ, Yuen AWC. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 1997;17:109-12
PubMed Web of Science ®Google Scholar
Lampl C, Katsarava Z, Diener HC, Limmroth V. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 2005;76:1730-2
PubMed Web of Science ®Google Scholar
Sances G, Martignoni E, Fioroni L, et al. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 1990;30:705-9
PubMed Web of Science ®Google Scholar
Newman LC, Lipton RB, Lay CL, Solomon S. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998;51:307-9
PubMed Web of Science ®Google Scholar
Newman L, Mannix LK, Landy S, et al. Naratriptan as short-term prophylaxis in menstrually associated migraine: a randomised, double-blind, placebo-controlled study. Headache 2001;41:248-56
PubMed Web of Science ®Google Scholar
Silberstein SD, Elkind AH, Schreiber C, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 2004;63:261-9
PubMed Web of Science ®Google Scholar
Mannix LK, Savani N, Landy S, et al. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache 2007;47:1037-49
PubMed Web of Science ®Google Scholar
Macgregor EA, Frith A, Ellis J, et al. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006;67:2159-63
PubMed Web of Science ®Google Scholar
Damen L, Bruijn J, Verhagen AP, et al. Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials. Cephalalgia 2006;26:497-505
PubMed Web of Science ®Google Scholar
Winner P, Pearlman EM, Linder SL, et al. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 2005;45:1304-12
PubMed Web of Science ®Google Scholar
Winner P, Gendolla A, Stayer C, et al. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. Headache 2006;46:1503-10
PubMed Web of Science ®Google Scholar
Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand 1974;50:109-15
PubMed Web of Science ®Google Scholar
Lütschg J, Vassella F. Behandlung der kindlichen Migräne mit Flunarizin bzw. Propranolol. Schweiz Med Wochenschr 1990;120:1731-6
PubMedGoogle Scholar
Lewis D, Ashwal S, Hershey A, et al. American academy of neurology quality standards subcommittee; practice committee of the child neurology society: practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 2004;63:2215-24
PubMed Web of Science ®Google Scholar
Sances G, Granella F, Nappi R, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003;23:197-205
PubMed Web of Science ®Google Scholar
Fox A, Diamond M, Spierings E. Migraine during pregnancy: options for therapy. CNS Drugs 2005;19:465-81
PubMed Web of Science ®Google Scholar
Silberstein SD, Lipton RB, Dodick DW, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007;47:170-80
PubMed Web of Science ®Google Scholar
Diener HC, Bussone G, Van Oene JC, et al. Topmat-Mig-201(TOP-CHROME) study group: topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007;27:814-23
PubMed Web of Science ®Google Scholar
Dodick DW, Mauskop A, Elkind AH, et al. Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 2005;45:315-24
PubMed Web of Science ®Google Scholar
Vahedi K, Taupin P, Djomby R, et al. Diamig investigators. Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial. J Neurol 2002;249:206-11
PubMed Web of Science ®Google Scholar
Noone JF. Clomipramine in the prevention of migraine. J Int Med Res 1980;8(Suppl 3):49-52
PubMed Web of Science ®Google Scholar
Diener HC, Krupp P, Schmitt T, et al. Cyclandelate in the prophylaxis of migraine: a placebo-controlled study. Cephalalgia 2001;21:66-70
PubMed Web of Science ®Google Scholar
Goldstein DJ, Offen WW, Klein EG, et al. Lanepitant, an NK-1 antagonist, in migraine prevention. Cephalalgia 2001;21:102-6
PubMed Web of Science ®Google Scholar
Brandes JL, Visser WH, Farmer MV, et al. Protocol 125 study group. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache 2004;44:581-6
PubMed Web of Science ®Google Scholar
Silberstein S, Saper J, Berenson F, et al. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study. Neurology 2008;70:548-55
PubMed Web of Science ®Google Scholar
Saper JR, Silberstein SD, Lake AE, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994;34:497-502
PubMed Web of Science ®Google Scholar
D'amato CC, Pizza V, Marmolo T, et al. Fluoxetine for migraine prophylaxis: a double-blind trial. Headache 1999;39:716-9
PubMedGoogle Scholar
Landy S, Mcginnis J, Curlin D, Laizure C. Selective serotonin reuptake inhibitors for migraine prophylaxis. Headache 1999;39:28-32
PubMed Web of Science ®Google Scholar
Whitmarsh TE, Coleston-Shields DM, Steiner TJ. Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine. Cephalalgia 1997;17:600-4
PubMed Web of Science ®Google Scholar
Ernst E. Homeopathic prophylaxis of headache and migraine. A systematic review. J Pain Symptom Manage 1999;18:353-7
PubMed Web of Science ®Google Scholar
Walach H, Lowes T, Mussbach D, et al. The long-term effects of homeopathic treatment of chronic headaches: 1 year follow up. Cephalalgia 2000;20:835-7
PubMed Web of Science ®Google Scholar
Straumsheim P, Borchgrevink C, Mowinckel P, et al. Homeopathic treatment of migraine: a double blind, placebo controlled trial of 68 patients. Br Homeopath J 2000;89:4-7
PubMedGoogle Scholar
Alemdar M, Akman O, Selekler HM, et al. Does metoprolol inhibit the cortical spreading depression? Acute effects of systematic metropol on CSD in rats. Cephalalgia 2007;27:1010-3
PubMed Web of Science ®Google Scholar
Ayata C, Jin H, Kudo C, et al. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006;59:652-61
PubMed Web of Science ®Google Scholar
Bowyer SM, Mason KM, Moran JE, et al. Cortical hyperexcitability in migraine patients before and after sodium valproate treatment. J Clin Neurophysiol 2005;22:65-7
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Treatment of migraine with prophylactic drugs

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment of migraine with prophylactic drugs

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date